Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Low molecular weight heparin, reviparin, after PTCA: results of a randomized double-blind, standard heparin and placebo controlled multicenter study (REDUCE Study].
Preisack MB, Baildon R, Eschenfelder V, Foley D, Garcia E, Kaltenbach M, Meisner C, Selbmann HK, Serruys PW, Shiu MF, Sujatta M, Bonan R, Karsch KR. Preisack MB, et al. Among authors: eschenfelder v. Z Kardiol. 1997 Aug;86(8):581-91. doi: 10.1007/s003920050097. Z Kardiol. 1997. PMID: 9417748 Clinical Trial. German.
Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
Karsch KR, Preisack MB, Baildon R, Eschenfelder V, Foley D, Garcia EJ, Kaltenbach M, Meisner C, Selbmann HK, Serruys PW, Shiu MF, Sujatta M, Bonan R. Karsch KR, et al. Among authors: eschenfelder v. J Am Coll Cardiol. 1996 Nov 15;28(6):1437-43. doi: 10.1016/s0735-1097(96)00343-9. J Am Coll Cardiol. 1996. PMID: 8917255 Free article. Clinical Trial.
Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty. A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial).
Preisack MB, Bonan R, Meisner C, Eschenfelder V, Karsch KR. Preisack MB, et al. Among authors: eschenfelder v. Eur Heart J. 1998 Aug;19(8):1232-8. doi: 10.1053/euhj.1998.1054. Eur Heart J. 1998. PMID: 9740345 Clinical Trial.
Preclinical studies on a low molecular weight heparin.
Fareed J, Jeske W, Eschenfelder V, Iqbal O, Hoppensteadt D, Ahsan A. Fareed J, et al. Among authors: eschenfelder v. Thromb Res. 1996;81(2 Suppl):S1-27. doi: 10.1016/0049-3848(95)00226-x. Thromb Res. 1996. PMID: 8822124
22 results